EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Nanotechnology in Prostate Cancer: PSMA-Targeted Nanoplatforms, TME-Responsive Therapy, Immunomodulation, and Clinical Translation Challenges

Wenjian Li iD

International Journal of Nanomedicine · 2026

DOI: 10.2147/ijn.s629751 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Wenjian Li. Beteiligte Einrichtung: Department of Urology, The Affiliated Changzhou Hospital of Xuzhou Medical University, Changzhou Third People's Hospital, Changzhou, Jiangsu, People'…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Antigens, Surface, Glutamate Carboxypeptidase II. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsAntigens, SurfaceGlutamate Carboxypeptidase IIHumansMaleTumor MicroenvironmentNanomedicineAnimalsTranslational Research, BiomedicalNanotechnologyImmunomodulationNanoparticlesDrug Delivery Systems

Stichwörter der Autor:innen

clinical translationintegrated diagnosis and treatmentnanotechnologyprostate cancertargeted delivery

Substanzen

Antigens, SurfaceGlutamate Carboxypeptidase IIFOLH1 protein, human

Autor:innen und Institutionen

  • Department of Urology, The Affiliated Changzhou Hospital of Xuzhou Medical University, Changzhou Third People's Hospital, Changzhou, Jiangsu, People's Republic of China.

ORCID-Profile: Wenjian Li

Zitieren

APA

Li, W. (2026). Nanotechnology in Prostate Cancer: PSMA-Targeted Nanoplatforms, TME-Responsive Therapy, Immunomodulation, and Clinical Translation Challenges. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s629751

Vancouver

Li W. Nanotechnology in Prostate Cancer: PSMA-Targeted Nanoplatforms, TME-Responsive Therapy, Immunomodulation, and Clinical Translation Challenges. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s629751

BibTeX
@article{Li2026,
  author = {Li, Wenjian},
  title = {Nanotechnology in Prostate Cancer: PSMA-Targeted Nanoplatforms, TME-Responsive Therapy, Immunomodulation, and Clinical Translation Challenges},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  doi = {10.2147/ijn.s629751}
}
Kostenlos starten →